Post-Thrombotic Syndrome: 2016 (CONG2016-36)
This activity includes the following:
Do Anticoagulant Strategies Impact the Incidence of PTS?
Jack Ansell, MD
Compression Therapy and PTS: Why the Controversy?
Fedor Lurie, MD, PhD, RPVI, RVT
Stenting and Chronic Iliocaval Occlusion
William Marston, MD
Update on the Attract Trial: How Could the Results Impact PTS?
Suresh Vedantham, MD
Molecular Interaction of Thrombus and Vein Wall: What Does the Future Hold?
Jose Diaz, MD
Question & Answer
All Faculty
Steps to Successfully Complete This Activity
To participate in this educational activity please follow the steps listed below.
If you are new to the ACP Online Education Center we require that you register prior to viewing any activity. Click the Register link located in the top right corner of this screen to do so. If you are already a registered user log in and click the TAKE COURSE button that will appear in the Course Summary box.
- To begin the activity click the START COURSE button.
- Progress through course content by using the NEXT button.
- Complete all required items in the course.
- Track your progress using the Course Progress menu.
- On the final page of the activity a link will be provided to download your certificate.
Target Audience
The primary target audience includes physicians, physician assistants and advanced registered nurse practitioners, ultrasound technologists, nurses, allied health and all other healthcare professionals currently or planning to care for patients with venous disease. Specialists focusing on phlebology, cardiology, general surgery, vascular surgery, interventional radiology, interventional cardiology, dermatology, dermatologic surgery, internal medicine, family practice, plastic surgery, obstetrics and gynecology, vascular medicine, and emergency medicine are invited to enhance their knowledge and skills specific to the treatment of venous and lymphatic disease.
Name | Role | Commercial Interest | Type of Relationship |
---|---|---|---|
Jack Ansell, MD | Speaker | 1. Bristol Myers Squibb 2. Daiichi Sankyo 3. Perosphere 4. Janssen | 1. Consultant 2. Consultant 3. Consultant; Equity Interest 4. Research |
Catherine Burdge, APRN | Content Reviewer | None | n/a |
Jose Diaz, MD | Speaker | None | n/a |
Sanjoy Kundu, MD, FSIR, fASA, DABR, FCIRSE | Content Reviewer | None | n/a |
Fedor Lurie, MD, PhD, RPVI, RVT | Speaker | None | n/a |
William Marston, MD | Speaker | 1. Veniti Inc. 2. Cardinal Healthcare 3. Tactile Medical 4. Tissue Tech | 1. Principal Investigator; Steering Committee 2. Advisory Board 3. Principal Investigator 4. Clinical Investigator |
Stephen H. Moss | Staff | None | n/a |
Diana Neuhardt, RPhS, RVT, FSVU | Content Reviewer | None | n/a |
Armen Roupenian, MD, FACS, RPVI, RVT, RPhS | Planner | None | n/a |
Suresh Vedantham, MD | Moderator; Speaker | 1. Cook 2. Volcano 3. BSN Medical | 1. Research Support to University Employer 2. Research Support to University Employer 3. Research Support to University Employer |
Disclaimer
The views and opinions expressed in this activity are those of the faculty and do not necessarily represent the views of the ACP. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic skills in applying or adopting professional use of any of the information provided herein. Links to other sites may be provided as additional sources of information. Once you elect to link to a site outside of ACP Education you are subject to the terms and conditions of use, including copyright and licensing restriction, of that site.
Discussion of Off-Label Use
Although no longer required by the Accreditation Council for Continuing Medical Education (ACCME), ACP CME requests all faculty to inform learners of any products they will discuss that are off-label or investigational.
Reproduction Prohibited
Reproduction of this material is not permitted without the express written permission from the copyright owner.